Cargando…

Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer

BACKGROUND: The aim of this study was to develop a scoring system to stratify the risk of papillary thyroid cancer (PTC) and to select the proper management. METHODS: We performed a systematic search of MEDLINE and Embase. Data regarding patients’ prognoses were obtained from the included studies. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Sunghwan, Goh, Tae Sik, Kim, Yun Hak, Oh, Sae-Ock, Pak, Kyoungjune, Seok, Ju Won, Kim, In Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386116/
https://www.ncbi.nlm.nih.gov/pubmed/32615728
http://dx.doi.org/10.3803/EnM.2020.35.2.435
_version_ 1783563889824235520
author Suh, Sunghwan
Goh, Tae Sik
Kim, Yun Hak
Oh, Sae-Ock
Pak, Kyoungjune
Seok, Ju Won
Kim, In Joo
author_facet Suh, Sunghwan
Goh, Tae Sik
Kim, Yun Hak
Oh, Sae-Ock
Pak, Kyoungjune
Seok, Ju Won
Kim, In Joo
author_sort Suh, Sunghwan
collection PubMed
description BACKGROUND: The aim of this study was to develop a scoring system to stratify the risk of papillary thyroid cancer (PTC) and to select the proper management. METHODS: We performed a systematic search of MEDLINE and Embase. Data regarding patients’ prognoses were obtained from the included studies. Odds ratios (ORs) with statistical significance were extracted from the publications. To generate a risk scoring system (RSS), ORs were summed (RSS1), and summed after natural-logarithmic transformation (RSS2). RSS1 and RSS2 were compared to the eighth edition of the American Joint Committee on Cancer (AJCC) staging system and the 2015 American Thyroid Association (ATA) guidelines for thyroid nodules and differentiated thyroid carcinoma. RESULTS: Five meta-analyses were eligible for inclusion in the study. Eight variables (sex, tumour size, extrathyroidal extension, BRAF mutation, TERT mutation, histologic subtype, lymph node metastasis, and distant metastasis) were included. RSS1 was the best of the analysed models. CONCLUSION: We developed and validated a new RSS derived from previous meta-analyses for patients with PTC. This RSS seems to be superior to previously published systems.
format Online
Article
Text
id pubmed-7386116
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-73861162020-07-29 Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer Suh, Sunghwan Goh, Tae Sik Kim, Yun Hak Oh, Sae-Ock Pak, Kyoungjune Seok, Ju Won Kim, In Joo Endocrinol Metab (Seoul) OriginalArticle BACKGROUND: The aim of this study was to develop a scoring system to stratify the risk of papillary thyroid cancer (PTC) and to select the proper management. METHODS: We performed a systematic search of MEDLINE and Embase. Data regarding patients’ prognoses were obtained from the included studies. Odds ratios (ORs) with statistical significance were extracted from the publications. To generate a risk scoring system (RSS), ORs were summed (RSS1), and summed after natural-logarithmic transformation (RSS2). RSS1 and RSS2 were compared to the eighth edition of the American Joint Committee on Cancer (AJCC) staging system and the 2015 American Thyroid Association (ATA) guidelines for thyroid nodules and differentiated thyroid carcinoma. RESULTS: Five meta-analyses were eligible for inclusion in the study. Eight variables (sex, tumour size, extrathyroidal extension, BRAF mutation, TERT mutation, histologic subtype, lymph node metastasis, and distant metastasis) were included. RSS1 was the best of the analysed models. CONCLUSION: We developed and validated a new RSS derived from previous meta-analyses for patients with PTC. This RSS seems to be superior to previously published systems. Korean Endocrine Society 2020-06 2020-06-30 /pmc/articles/PMC7386116/ /pubmed/32615728 http://dx.doi.org/10.3803/EnM.2020.35.2.435 Text en Copyright © 2020 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle OriginalArticle
Suh, Sunghwan
Goh, Tae Sik
Kim, Yun Hak
Oh, Sae-Ock
Pak, Kyoungjune
Seok, Ju Won
Kim, In Joo
Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
title Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
title_full Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
title_fullStr Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
title_full_unstemmed Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
title_short Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
title_sort development and validation of a risk scoring system derived from meta-analyses of papillary thyroid cancer
topic OriginalArticle
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386116/
https://www.ncbi.nlm.nih.gov/pubmed/32615728
http://dx.doi.org/10.3803/EnM.2020.35.2.435
work_keys_str_mv AT suhsunghwan developmentandvalidationofariskscoringsystemderivedfrommetaanalysesofpapillarythyroidcancer
AT gohtaesik developmentandvalidationofariskscoringsystemderivedfrommetaanalysesofpapillarythyroidcancer
AT kimyunhak developmentandvalidationofariskscoringsystemderivedfrommetaanalysesofpapillarythyroidcancer
AT ohsaeock developmentandvalidationofariskscoringsystemderivedfrommetaanalysesofpapillarythyroidcancer
AT pakkyoungjune developmentandvalidationofariskscoringsystemderivedfrommetaanalysesofpapillarythyroidcancer
AT seokjuwon developmentandvalidationofariskscoringsystemderivedfrommetaanalysesofpapillarythyroidcancer
AT kiminjoo developmentandvalidationofariskscoringsystemderivedfrommetaanalysesofpapillarythyroidcancer